Redefining Reference Standards

What is the impact of molecular assay failure in your laboratory?
Identify and eliminate variability in your laboratory today

Webinars

You are here: Home / Connect With Us / Webinars

The following complimentary webcasts are scheduled. Please register to participate.

Please be aware that webinars are hosted through GoToWebinar. If you are not already set up to view webinars through this service, please allow 5 minutes before the start to establish access.

Register for upcoming webinars here:


The Clinical Application, Development and Validation of Cell-free DNA Assays/Platforms


Date: October 23rd, 2014
Time: 16:00-16:40 BST (London time)

Register your place here


About the Webinar

Molecular characterisation of circulating tumor cells (CTCs) and/or cell free tumor DNA (cfDNA) offers the opportunity for personalized targeted therapy and real-time monitoring of treatment efficacy. 

The development of novel platforms to assess the presence of cfDNA is challenging due to the difficulty in obtaining a sustainable source of patient-relevant material. This webinar presents how the design and validation of our Multiplex Low Copy Number HDx™ Reference Standards and their performance in assays optimised for cfDNA detection. 

We will discuss the clinical application, development and validation of Cell-free DNA assays. 

Topics

  • What are the clinical applications of cfDNA?
  • Is there a place for cfDNA in personalized medicine?
  • How do you optimize your assay for cfDNA detection?

Meet the presenters

Jonathan Frampton, PhD

In his role, Jonathan works closely with a broad range of European, North American and EMEA oncology-focussed Quality Assurance Schemes with the goal of driving the standardization and normalization of molecular assays across the globe.Jonathan holds a PhD from University of Sussex in Genomic DNA Damage and Stability and has extensive product development experience through previous roles including Cambridge-based antibody company Abcam.

Hadas Amit, PhD

Hadas is a senior scientist with a strong interest in the future of personalised medicine with focus on advances in cell free tumor DNA (cfDNA). Hadas is leading the research and development of cfDNA Reference Standards at Horizon Diagnostics. 

 

Who should attend?

This webinar is aimed at molecular pathologists and for all those involved in any part of Quality Control.

 

Contact Horizon Diagnostics

For all technical enquiries, please contact us at technical@horizondx.com

 

About Horizon Diagnostics

Horizon Diagnostics, a business unit of Horizon Discovery Group plc is proud to support clinical laboratories with the provision of reference materials for research use; applications include the validation of equipment and consumables offline from patient testing. HDx™ Reference Standards are manufactured within a Quality Management System which complies with the requirements of ISO 9001:2008 and ISO 13485:2003.

Paragraph explaining benefits of Biocair

×

Login Error


There was an error with your login - please try again.

Forgotten your password? Click here

OK ×

Recover your password

Please enter your email address and we'll send you a reset link

×

Thank you.


We've sent you an email to reset your password.

OK ×

Add Voucher


Sorry, Unable to add voucher

OK ×

Account Error


There was an error updating your details.

OK ×

Thank you.


Your changes have been saved.

OK ×

Thank you


Thank you for registering to the Horizon DX website. We hope you enjoy and benefit from our online resources, and please feel free to contact us if you have any queries or feedback through the website itself or at info@horizondx.com.


×

Thank you.


Items have been saved to your basket.

OK ×